Market Scenario 

Ambulatory surgical centers market was valued at US$ 85.9 billion in 2024 and is projected to hit the market valuation of US$ 142.6 billion by 2033 at a CAGR of 5.8% during the forecast period 2025–2033.

The rising demand for Ambulatory Surgical Centers (ASCs) is being fueled by their cost-efficiency and ability to provide high-quality patient outcomes. ASCs consistently offer more affordable options compared to hospital outpatient departments. For instance, the cost of a colonoscopy with biopsy at an ASC in the US is approximately $1,089, while the same procedure costs $1,766 at a hospital. Similarly, cataract removal expenses stand at $2,410 in ASCs versus $3,727 in hospitals. This affordability extends to Medicare beneficiaries, as Medicare covers $976 for cataract surgery at an ASC compared to $1,745 for the same procedure at a hospital. Moreover, recent regulatory updates have further boosted the market. For example, the Centers for Medicare & Medicaid Services (CMS) has introduced a 2.6% reimbursement rate increase for ASCs in 2025 and has broadened the list of approved procedures, particularly in the fields of cardiovascular and orthopedic surgeries.

The Ambulatory surgical center market expansion is also driven by high patient satisfaction and operational efficiency, which are hallmarks of ASCs. Surveys reveal that patients are more likely to recommend ASCs due to their faster service, reduced wait times, and personalized care when compared to hospital outpatient departments. Orthopedic surgeries, in particular, are seeing a significant shift toward ASCs. By 2024, an estimated 7.8 million orthopedic procedures will be conducted annually, with demand expected to grow steadily through 2028. This shift is further supported by technological advancements, such as robotic-assisted surgeries and cutting-edge imaging systems. These innovations allow ASCs to perform more complex procedures with improved precision and better patient outcomes, making them a preferred choice for both patients and physicians.

The Ambulatory surgical center market is undergoing rapid transformation, driven by innovation and expanded capabilities. The adoption of artificial intelligence and machine learning is playing a significant role in improving diagnostic accuracy and streamlining surgical workflows. Additionally, telemedicine is becoming increasingly integrated into patient follow-up and engagement, enhancing the overall care experience. In the orthopedic space alone, the global market is forecasted to reach nearly $70 billion by 2030, driven by aging populations and technological progress. The CMS’s introduction of three new health equity measures for the ASC Quality Reporting Program in 2025 further emphasizes the sector’s focus on improving healthcare accessibility and transparency, solidifying its role as a key component of modern outpatient care. 

To Get more Insights,  Request A Free Sample 

 Market Dynamics 

Driver: Growing Demand for Cost-Effective Outpatient Surgeries Across Patient Populations

The ambulatory surgical center market is witnessing unprecedented growth, largely driven by the increasing demand for cost-effective outpatient surgeries. Patients, payers, and healthcare systems alike are prioritizing affordability without compromising quality, making ASCs a preferred option. A key factor is the stark cost difference between ASCs and hospital outpatient departments (HOPDs). For example, a colonoscopy with biopsy costs approximately US$ 1,089 at an ASC compared to US$ 1,766 at a hospital. Similarly, a cataract removal procedure costs US$ 2,410 at an ASC versus US$ 3,727 in a hospital setting. These cost savings are significant not only for individual patients but also for Medicare beneficiaries and private insurers. With Medicare reimbursing US$ 976 for cataract surgeries performed at ASCs compared to US$ 1,745 at hospitals, ASCs are helping reduce financial burdens on the healthcare system. This cost advantage is especially critical as the U.S. healthcare market continues to combat rising expenditures.

The increasing preference for ASCs extends beyond affordability. Patients are drawn to these facilities for their efficiency, shorter wait times, and lower infection risks compared to hospitals. Furthermore, ASCs now cater to a broader range of procedures, including orthopedic and cardiovascular surgeries, thanks to advancements in surgical techniques and equipment. By 2024, the U.S. is projected to perform 7.8 million orthopedic procedures annually, with a significant portion occurring in ASCs. This shift is supported by CMS policies, which have expanded the list of ASC-approved procedures over the years. For market stakeholders, these trends indicate that ASCs are not just a cost-saving alternative but a vital part of the evolving healthcare ecosystem, offering value-based care for a growing and aging population.

Trend: Surge in Robotic-Assisted Surgeries Performed in Ambulatory Surgical Centers

The ambulatory surgical center market is undergoing a technological transformation, with robotic-assisted surgeries becoming a dominant trend. ASCs are increasingly adopting advanced robotic systems to perform complex procedures that were once confined to hospitals. These systems enhance precision, reduce recovery times, and improve patient outcomes. For instance, robotic-assisted surgeries are becoming common in orthopedics, where they are used for partial and total joint replacements. The efficiency of these systems allows ASCs to handle a higher volume of patients while maintaining quality. By 2024, the global orthopedic segment is expected to see significant growth, with ASCs playing a crucial role in meeting the rising demand for such advanced surgical solutions. Additionally, the integration of robotics aligns with the growing consumer demand for minimally invasive procedures, which offer quicker recovery and less postoperative pain.

The financial implications of robotic systems in ASCs are also notable. While the initial investment for robotics can be high, the return on investment is substantial due to increased patient throughput and higher reimbursement rates for robotic-assisted surgeries. Some ASCs have reported adding an additional 10 to 15 surgeries per month due to robotics, translating into higher revenues and improved operational efficiency. Moreover, advancements in robotic technology are making these systems more accessible to smaller, independent ASCs, leveling the playing field in the competitive ambulatory surgical center market. As robotics adoption continues to grow, stakeholders should anticipate a shift in the market landscape, with ASCs becoming synonymous with cutting-edge surgical care, supported by technologies that were previously only available in hospital settings.

Challenge: High Competition Between ASCs and Hospital Outpatient Departments for Patients

In the ambulatory surgical center market, one of the most significant challenges is the intense competition between ASCs and hospital outpatient departments (HOPDs) for patients. ASCs are recognized for their cost efficiency, but HOPDs often leverage their brand reputation, wider service offerings, and established patient bases to maintain market share. For example, hospitals often bundle outpatient services with inpatient care, making it convenient for patients to choose HOPDs over standalone ASCs. Additionally, hospitals frequently have larger marketing budgets and greater access to resources, allowing them to attract a broader demographic. This dynamic creates a competitive environment where ASCs must differentiate themselves through superior service quality, faster turnaround times, and affordability to capture patient loyalty.

Another factor influencing competition is payer dynamics. While ASCs generally offer lower costs for the same procedures, hospitals often negotiate higher reimbursement rates with insurance companies due to their scale and bargaining power. This can create a financial incentive for payers to steer patients toward HOPDs, despite the cost advantage of ASCs. Furthermore, hospitals are increasingly acquiring ASCs, blurring the lines between the two segments and intensifying competition. As of 2024, this trend is expected to grow, with large healthcare systems expanding their outpatient surgery portfolios to compete directly in the ambulatory surgical center market. For ASC operators, maintaining independence while navigating these challenges requires a strategic approach, including investing in advanced technologies, building strong physician networks, and focusing on patient-centric care to sustain their competitive edge.

 Segmental Analysis 

By Ownership

Physician-only ownership dominates the ambulatory surgical center market, holding more than 59.56% of the total market share. This dominance is driven by the inherent advantages of physician-led facilities, particularly their ability to provide streamlined, patient-focused care. Physicians owning ASCs have greater flexibility in decision-making, allowing them to optimize staffing, procurement, and scheduling processes. This control helps reduce administrative overhead and operational inefficiencies that are common in hospital-owned ASCs. Additionally, physician ownership aligns the financial incentives of providers and the facility, motivating physicians to prioritize efficiency and patient satisfaction. For instance, orthopedic surgeons often prefer owning ASCs because they can standardize workflows for high-demand procedures like joint replacements and arthroscopies, leading to faster turnaround times and better outcomes for patients.

Another critical driver of physician-only ownership is its ability to meet the rising demand for specialized outpatient care. Physician-owned ASCs often focus on profitable specialties such as orthopedics, ophthalmology, and gastroenterology, where high procedural volumes ensure steady revenue streams. These facilities are also better positioned to adopt advanced surgical technologies, such as robotic systems and minimally invasive tools, further enhancing their appeal to both patients and payers. Moreover, private equity investments in physician-only ASCs are increasing, as investors recognize the potential for high returns in this model. For example, the U.S. has seen a surge in private equity-backed ASC partnerships, with many focusing on physician-driven facilities that can quickly adapt to market demands. These factors collectively position physician-only ownership as a dominant force within the ambulatory surgical center market.

By Surgery 

Otolaryngology surgeries account for 23.51% of the ambulatory surgical center market, driven by the global burden of ear, nose, and throat (ENT) disorders. Chronic sinusitis, sleep apnea, and hearing loss are among the most prevalent conditions requiring surgical intervention. For instance, the World Health Organization reports that over 430 million people globally need treatment for disabling hearing loss, with surgery often being the primary solution. Similarly, chronic sinusitis affects approximately 30 million adults annually in the U.S. alone, many of whom undergo sinus surgeries at ASCs. Ambulatory surgical centers cater to this demand by offering cost-effective, same-day procedures that minimize downtime for patients. Common ENT surgeries performed at ASCs include tonsillectomies, sinus surgeries, and tympanoplasty, which are particularly popular due to their minimally invasive nature and quick recovery times.

The dominance of otolaryngology surgeries is also fueled by advancements in technology and the growing preference for outpatient care. Procedures once considered too complex for ASCs, such as cochlear implantations and balloon sinuplasty, are now routinely performed thanks to innovations in surgical tools and imaging systems. Pediatric patients are a key demographic, as they frequently require tonsillectomies and adenoidectomies, while aging populations drive demand for hearing-related surgeries. Furthermore, partnerships between ASCs and ENT specialists are expanding, with many facilities dedicating resources exclusively to otolaryngology care. These partnerships ensure that patients receive specialized treatment, while providers benefit from the operational efficiencies of a focused care model. As ENT disorders continue to rise globally, otolaryngology surgeries will remain a cornerstone of the ambulatory surgical center market.

By Services

Treatment services lead the ambulatory surgical center market, as the primary function of ASCs is to deliver surgical interventions in a cost-effective and efficient manner. ASCs are designed to handle same-day surgeries, making them ideal for treatments like joint replacements, cataract removals, hernia repairs, and laparoscopic procedures. These treatments are not only less expensive compared to hospital settings but also offer reduced recovery times, lower infection risks, and improved patient outcomes. For instance, advancements in minimally invasive techniques enable ASCs to perform complex surgeries, such as spinal fusions and cardiac catheterizations, with minimal disruption to patients’ daily lives. This focus on treatments aligns with the growing demand for outpatient procedures, as patients and payers alike seek alternatives to costly inpatient care.

The dominance of treatment services in the ambulatory surgical center market is also supported by favorable reimbursement structures. Medicare and private insurers are increasingly incentivizing providers to shift procedures to ASCs by offering higher reimbursement rates for outpatient treatments performed in these centers. Furthermore, the integration of advanced surgical technologies, such as robotic-assisted systems and real-time imaging, has expanded the range of treatments that can be performed in ASCs. While diagnostic services are essential, they remain secondary to treatments, as ASCs are primarily equipped and staffed to handle surgical interventions. This trend underscores the critical role of ASCs in addressing the rising demand for high-quality, accessible, and affordable treatment options, solidifying their position as a key player in the healthcare industry.

By Specialty Type

Single-specialty centers account for more than 60% of the ambulatory surgical center market, outperforming their multispecialty counterparts due to their focused operational models. These facilities are designed to cater to specific medical fields, such as orthopedics, ophthalmology, gastroenterology, or urology, enabling them to optimize resources and deliver superior outcomes. A single-specialty ASC, for example, can perform dozens of cataract surgeries or endoscopies in a single day, significantly reducing costs and increasing efficiency. This streamlined approach not only benefits patients, who experience shorter wait times and lower costs, but also providers, who can perform high volumes of procedures with minimal logistical challenges. Additionally, single-specialty ASCs are often equipped with specialized tools and staff that enhance procedural precision and outcomes, ensuring a higher level of care.

The preference for single-specialty centers in the ambulatory surgical center market is also linked to their ability to meet regulatory requirements more efficiently than multispecialty facilities. By focusing on a single area of care, these centers face fewer compliance challenges, allowing them to invest more resources in technology and patient care. Patients also perceive single-specialty ASCs as experts in their chosen field, which strengthens patient trust and loyalty. For instance, orthopedic ASCs have seen a surge in demand due to the rising prevalence of sports injuries and age-related joint issues, while gastroenterology ASCs cater to the increasing need for colonoscopies and endoscopies. As the healthcare industry continues to prioritize value-based care, single-specialty ASCs are expected to maintain their dominance by offering targeted, efficient, and high-quality services.

 To Understand More About this Research:  Request A Free Sample 

Regional Analysis 

North America Leading the Ambulatory Surgical Center Market

North America holds a leading position in the ambulatory surgical center market, capturing more than 26.46% of the global share. This dominance is attributed to a well-established healthcare system, a growing preference for outpatient surgeries, and favorable reimbursement policies. The region’s aging population and increasing prevalence of chronic diseases, such as osteoarthritis and cardiovascular conditions, have fueled the demand for cost-effective surgical care. ASCs meet this demand by offering high-quality, same-day procedures at reduced costs compared to hospitals. Additionally, advancements in surgical technologies, such as robotic-assisted surgeries and minimally invasive techniques, have expanded the scope of procedures performed in ASCs across North America.

The region’s ASC growth is significantly boosted by regulatory support. Medicare and private insurers actively promote outpatient surgeries by offering attractive reimbursement rates. Moreover, the focus on value-based care has reinforced the importance of ASCs as a cost-effective alternative to hospitals. Canada, while smaller in market size, is also seeing steady ASC adoption due to its focus on reducing hospital wait times. North America’s robust healthcare infrastructure, combined with technological advancements and policy incentives, continues to strengthen its leadership in the ambulatory surgical center market.

• The US Driving Market Dominance in North America

The US is the primary driver of North America’s dominance in the ambulatory surgical center market, accounting for the majority share in the region. With over 5,700 Medicare-certified ASCs, the US has established a vast network of outpatient surgical centers offering specialized care in orthopedics, ophthalmology, gastroenterology, and cardiology. The country’s high penetration of ASCs is fueled by a rapidly aging population and a growing preference for minimally invasive surgeries. For example, joint replacements, cataract surgeries, and colonoscopies are among the most in-demand ASC procedures, meeting the needs of millions of patients annually.

Demand for ASCs in the US is further driven by favorable reimbursement structures. The Centers for Medicare & Medicaid Services (CMS) has expanded the list of ASC-approved procedures, making outpatient care more financially viable for providers and patients. Additionally, private equity investments in ASCs have surged, with healthcare systems and investors recognizing the profitability of these centers. States like California, Texas, and Florida are leading in ASC adoption due to their large populations and significant healthcare demand. With its advanced healthcare infrastructure, the US remains a global benchmark for the ambulatory surgical center market.

Asia Pacific Emerging as a Key Growth Region

Asia Pacific is rapidly gaining traction in the ambulatory surgical center market, driven by a growing middle class, higher healthcare expenditures, and increasing demand for outpatient care. Countries like India, China, and Japan are leading the region’s ASC growth. Chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal issues are prevalent, creating a rising need for surgical interventions. Additionally, government initiatives in countries like India and China aim to expand healthcare access by promoting outpatient surgical facilities in both urban and rural regions.

Technological advancements and private sector investments are also fueling ASC growth in Asia Pacific. For instance, Japan’s aging population has driven the demand for orthopedic and ophthalmologic procedures, while China and India are increasingly adopting minimally invasive surgeries for conditions like gallbladder removal and hernia repair. The region’s growing healthcare infrastructure and increasing awareness of the benefits of outpatient surgeries ensure its rising prominence in the ambulatory surgical center market. Asia Pacific is expected to witness robust growth in the coming years as healthcare access continues to expand and demand for cost-effective care rises.

Europe’s Position in the Market

Europe is the third-largest region in the ambulatory surgical center market, driven by its strong focus on healthcare quality and efficiency. Countries like Germany, the UK, and France are leading the region’s ASC adoption, leveraging the benefits of outpatient surgeries to reduce hospital burdens and improve patient outcomes. Europe’s aging population and increasing prevalence of chronic diseases, such as arthritis and cardiovascular conditions, have significantly fueled demand for outpatient surgical services. For example, cataract surgeries and joint replacements are among the most common procedures performed in European ASCs.

The European market benefits from government initiatives promoting outpatient care. In Germany, for instance, health authorities have encouraged the use of ASCs to address hospital overcrowding and reduce healthcare costs. Similarly, the UK’s National Health Service (NHS) has invested in outpatient surgical programs to meet growing demand. While Europe has a relatively slower adoption rate compared to North America, ongoing investments in healthcare infrastructure and the increasing acceptance of minimally invasive techniques are expected to drive ASC growth across the region in the coming years.

Top Companies in the Ambulatory Surgical Centers Market

• CHSPSC, LLC.
• Eifelhöhen-Klinik AG
• Edward-Elmhurst Health
• Healthway Medical Group
• Envision Healthcare Corporation
• Nexus Day Surgery Centre
• Pediatrix Medical Group
• Prospect Medical Holdings, Inc.
• Surgery Partners
• SurgCenter
• TH Medical
• UNITEDHEALTH GROUP
• Other Prominent Players

Market Segmentation Overview

By Ownership

• Physician Only
• Hospital Only
• Corporation Only
• Physician & Hospital
• Physician & Corporation
• Hospital & Corporation

By Surgery Type

• Dental
• Otolaryngology
• Endoscopy
• Obstetrics / Gynecology
• Opthalmology
• Orthopedic
• Cardiovascular
• Neurology
• Plastic Surgery
• Podiatry
• Others

By Specialty Type

• Multi-specialty
• Single specialty

By Service

• Diagnosis
• Treatment

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Hungary
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • UAE
  • Saudi Arabia
  • Bahrain
  • Kuwait
  • Qatar
  • Rest of Middle East
• Africa
  • Oman
  • Egypt
  • Nigeria
  • South Africa
  • Rest of Africa
• South America
  • Argentina
  • Brazil
  • Rest of South America